Rybelsus emerges as a significant player in the management of type 2 diabetes, primarily due to its innovative mechanism of action. This medication, delivered orally, represents a leap forward in glucagon-like peptide-1 (GLP-1) receptor agonists. The active ingredient, semaglutide, mimics the effects of the GLP-1 hormone, which plays a crucial…